224 related articles for article (PubMed ID: 18760996)
1. Role of TLR9 in hepatic stellate cells and experimental liver fibrosis.
Gäbele E; Mühlbauer M; Dorn C; Weiss TS; Froh M; Schnabl B; Wiest R; Schölmerich J; Obermeier F; Hellerbrand C
Biochem Biophys Res Commun; 2008 Nov; 376(2):271-6. PubMed ID: 18760996
[TBL] [Abstract][Full Text] [Related]
2. LPS signaling enhances hepatic fibrogenesis caused by experimental cholestasis in mice.
Isayama F; Hines IN; Kremer M; Milton RJ; Byrd CL; Perry AW; McKim SE; Parsons C; Rippe RA; Wheeler MD
Am J Physiol Gastrointest Liver Physiol; 2006 Jun; 290(6):G1318-28. PubMed ID: 16439470
[TBL] [Abstract][Full Text] [Related]
3. Effects of a new bioactive lipid-based drug carrier on cultured hepatic stellate cells and liver fibrosis in bile duct-ligated rats.
Adrian JE; Poelstra K; Scherphof GL; Meijer DK; van Loenen-Weemaes AM; Reker-Smit C; Morselt HW; Zwiers P; Kamps JA
J Pharmacol Exp Ther; 2007 May; 321(2):536-43. PubMed ID: 17314198
[TBL] [Abstract][Full Text] [Related]
4. Anti-fibrotic activity of NK cells in experimental liver injury through killing of activated HSC.
Melhem A; Muhanna N; Bishara A; Alvarez CE; Ilan Y; Bishara T; Horani A; Nassar M; Friedman SL; Safadi R
J Hepatol; 2006 Jul; 45(1):60-71. PubMed ID: 16515819
[TBL] [Abstract][Full Text] [Related]
5. CpG motif-independent activation of TLR9 upon endosomal translocation of "natural" phosphodiester DNA.
Yasuda K; Rutz M; Schlatter B; Metzger J; Luppa PB; Schmitz F; Haas T; Heit A; Bauer S; Wagner H
Eur J Immunol; 2006 Feb; 36(2):431-6. PubMed ID: 16421948
[TBL] [Abstract][Full Text] [Related]
6. Sustained activation of Rac1 in hepatic stellate cells promotes liver injury and fibrosis in mice.
Choi SS; Sicklick JK; Ma Q; Yang L; Huang J; Qi Y; Chen W; Li YX; Goldschmidt-Clermont PJ; Diehl AM
Hepatology; 2006 Nov; 44(5):1267-77. PubMed ID: 17058265
[TBL] [Abstract][Full Text] [Related]
7. Activated hepatic stellate cells in liver cirrhosis. A morphologic and morphometrical study.
Carpino G; Franchitto A; Morini S; Corradini SG; Merli M; Gaudio E
Ital J Anat Embryol; 2004; 109(4):225-38. PubMed ID: 15717457
[TBL] [Abstract][Full Text] [Related]
8. Neutrophil recognition of bacterial DNA and Toll-like receptor 9-dependent and -independent regulation of neutrophil function.
El Kebir D; József L; Filep JG
Arch Immunol Ther Exp (Warsz); 2008; 56(1):41-53. PubMed ID: 18250968
[TBL] [Abstract][Full Text] [Related]
9. Loss of Sept4 exacerbates liver fibrosis through the dysregulation of hepatic stellate cells.
Iwaisako K; Hatano E; Taura K; Nakajima A; Tada M; Seo S; Tamaki N; Sato F; Ikai I; Uemoto S; Kinoshita M
J Hepatol; 2008 Nov; 49(5):768-78. PubMed ID: 18804890
[TBL] [Abstract][Full Text] [Related]
10. Antitumor effect of OK-432-derived DNA: one of the active constituents of OK-432, a streptococcal immunotherapeutic agent.
Oshikawa T; Okamoto M; Tano T; Sasai A; Kan S; Moriya Y; Ryoma Y; Saito M; Akira S; Sato M
J Immunother; 2006; 29(2):143-50. PubMed ID: 16531815
[TBL] [Abstract][Full Text] [Related]
11. Role of pathogenic auto-antibody production by Toll-like receptor 9 of B cells in active systemic lupus erythematosus.
Nakano S; Morimoto S; Suzuki J; Nozawa K; Amano H; Tokano Y; Takasaki Y
Rheumatology (Oxford); 2008 Feb; 47(2):145-9. PubMed ID: 18160420
[TBL] [Abstract][Full Text] [Related]
12. Elucidation of the role of COX-2 in liver fibrogenesis using transgenic mice.
Yu J; Wu CW; Chu ES; Hui AY; Cheng AS; Go MY; Ching AK; Chui YL; Chan HL; Sung JJ
Biochem Biophys Res Commun; 2008 Aug; 372(4):571-7. PubMed ID: 18503750
[TBL] [Abstract][Full Text] [Related]
13. TLR9 expression is related to immune activation but is impaired in individuals with chronic immune activation.
Ayash-Rashkovsky M; Bentwich Z; Borkow G
Int J Biochem Cell Biol; 2005 Nov; 37(11):2380-94. PubMed ID: 16024265
[TBL] [Abstract][Full Text] [Related]
14. Apoptotic hepatocyte DNA inhibits hepatic stellate cell chemotaxis via toll-like receptor 9.
Watanabe A; Hashmi A; Gomes DA; Town T; Badou A; Flavell RA; Mehal WZ
Hepatology; 2007 Nov; 46(5):1509-18. PubMed ID: 17705260
[TBL] [Abstract][Full Text] [Related]
15. Effects of RNA interference targeting transforming growth factor-beta 1 on immune hepatic fibrosis induced by Concanavalin A in mice.
Xu W; Wang LW; Shi JZ; Gong ZJ
Hepatobiliary Pancreat Dis Int; 2009 Jun; 8(3):300-8. PubMed ID: 19502172
[TBL] [Abstract][Full Text] [Related]
16. The immunophysiological impact of bacterial CpG DNA on the gut.
Watson JL; McKay DM
Clin Chim Acta; 2006 Feb; 364(1-2):1-11. PubMed ID: 16153626
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms of TLR9 activation.
Latz E; Visintin A; Espevik T; Golenbock DT
J Endotoxin Res; 2004; 10(6):406-12. PubMed ID: 15588423
[TBL] [Abstract][Full Text] [Related]
18. The DNA sugar backbone 2' deoxyribose determines toll-like receptor 9 activation.
Haas T; Metzger J; Schmitz F; Heit A; Müller T; Latz E; Wagner H
Immunity; 2008 Mar; 28(3):315-23. PubMed ID: 18342006
[TBL] [Abstract][Full Text] [Related]
19. Hepatic stellate cells secrete angiopoietin 1 that induces angiogenesis in liver fibrosis.
Taura K; De Minicis S; Seki E; Hatano E; Iwaisako K; Osterreicher CH; Kodama Y; Miura K; Ikai I; Uemoto S; Brenner DA
Gastroenterology; 2008 Nov; 135(5):1729-38. PubMed ID: 18823985
[TBL] [Abstract][Full Text] [Related]
20. Fibrogenesis in pediatric cholestatic liver disease: role of taurocholate and hepatocyte-derived monocyte chemotaxis protein-1 in hepatic stellate cell recruitment.
Ramm GA; Shepherd RW; Hoskins AC; Greco SA; Ney AD; Pereira TN; Bridle KR; Doecke JD; Meikle PJ; Turlin B; Lewindon PJ
Hepatology; 2009 Feb; 49(2):533-44. PubMed ID: 19115220
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
